Among its multiple tumor-promoting functions, the HER-2-dependent activation of nuclear factor-kappa B (NF-kB) relates to its enhanced invasive properties and resistance to anticancer treatments [25,26]. This evidence concerns the gene NFKB1 and neoplasm.